1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells

Oncology Reports

Volumn 19, Issue 5, 2008, Pages 1155-1164

  Wang, Jin ^a,c   Tai, Lai Shan ^b   Tzang, Chi Hung ^a   Fong, Wan Fong ^a   Guan, Xin Yuan ^b   Yang, Mengsu ^a  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

CGH; Chromosomal aberration; KB cell; Microarray; Multidrug resistance

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ASPARAGINE TRANSFER RNA; ATP BINDING CASSETTE B4; CYSTEINE RICH PROTEIN 61; DOXORUBICIN; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 1; MINICHROMOSOME MAINTENANCE PROTEIN 7; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCURONIC ACID; VINBLASTINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL STRAIN KB; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UPREGULATION; UTERINE CERVIX CARCINOMA; CELL CYCLE; CHROMOSOME 1; CHROMOSOME 18; CHROMOSOME 7; FEMALE; GENETICS; NUCLEIC ACID HYBRIDIZATION; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 7; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KB CELLS; NUCLEIC ACID HYBRIDIZATION; UTERINE CERVICAL NEOPLASMS; VINBLASTINE;

EID: 47549107093     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.5.1155     Document Type: Article

References (30)

1. Van der Bliek AM, Baas F, van der Velde-Koerts T, et al: Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res 48: 5927-5932, 1988.
2. Futscher BW, Abbaszadegan MR, Domann F and Dalton WS: Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. Biochem Pharmacol 47: 1601-1606, 1994.
3. Middleton MR and Margison GP: Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway. Lancet Oncol 4: 37-44, 2003.
4. Bell SE, Quinn DM, Kellett GL and Warr JR: 2-Deoxy-D-glucose preferentially kills multidrug-resistant human KB carcinoma cell lines by apoptosis. Br J Cancer 78: 1464-1470, 1998.
5. Kallioniemi A, Kallioniemi OP, Piper J, et al: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91: 2156-2160, 1994.
6. Pinkel D and Albertson DG: Comparative genomic hybridization. Annu Rev Genomics Hum Genet 6: 331-354, 2005.
7. Monni O, Barlund M, Mousses S, et al: Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA 98: 5711-5716, 2001.
8. Schena M, Shalon D, Davis RW and Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470, 1995.
9. Duggan DJ, Bittner M, Chen Y, Meltzer P and Trent JM: Expression profiling using cDNA microarrays. Nat Genet 21: 10-14, 1999.
10. Sakamoto M, Kondo A, Kawasaki K, et al: Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray. Hum Cell 14: 305-315, 2001.
11. Kudoh K, Ramanna M, Ravatn R, et al: Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 60: 4161-4166, 2000.
12. Komatani H, Kotani H, Hara Y, Nakagawa R, Matsumoto M, Arakawa H and Nishimura S: Identification of breast cancer resistant protein/ mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure. Cancer Res 61: 2827-2832, 2001.
13. Levenson VV, Davidovich IA and Roninson IB: Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair and stress response. Cancer Res 60: 5027-5030, 2000.
14. Skehan P, Storeng R, Scudiero D, et al: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112, 1990.
15. Guan XY, Fang Y, Sham JS, et al: Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 29: 110-116, 2000.
16. Zhang Y, Song S, Fong CC, Tsang ZH, Yang Z and Yang M: cDNA microarray analysis of gene expression profiles in human fibroblast cells irradiated with red light. J Invest Dermatol 120: 849-857, 2003.
17. Chen GK, Lacayo NJ, Duran GE, et al: Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma. Genes Chromosomes Cancer 34: 372-383, 2002.
18. Takano M, Kudo K, Goto T, Yamamoto K, Kita T and Kikuchi Y: Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer. Hum Cell 14: 267-271, 2001.
19. Tonnies H, Poland J, Sinha P and Lage H: Association of genomic imbalances with drug resistance and thermoresistance in human gastric carcinoma cells. Int J Cancer 103: 752-816, 2003.
20. Luciani F, Molinari A, Lozupone F, et al: P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin. Blood 99: 641-648, 2002.
21. Hong JH, Lee E, Hong J, Shin YJ and Ahn H: Antisense Bc12 oligonucleotide in cisplatin-resistant bladder cancer cell lines. BJU Int 90: 113-117, 2002.
22. Frankel AE, Schuster MW and Jurcic JG: Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia. Bio Drugs 15: 55-71, 2001.
23. Kim PK, Mahidhara R and Seol DW: The role of caspase-8 in resistance to cancer chemotherapy. Drug Resist Updat 4: 293-296, 2001.
24. Hofmann WK, De Vos S, Elashoff D, Gschaidmeier H, Hoelzer D, Koeffier HP and Ottmann OG: Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor ST1571 and gene-expression profiles: a gene-expression study. Lancet 359: 481-486, 2002.
25. Schlegel J, Guneysu S and Mennel HD: Expression of the genes of methyl-binding domain proteins in human gliomas. Oncol Rep 9: 393-395, 2002.
26. Leu SJ, Lam SC and Lau LF: Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem 277: 46248-46255, 2002.
27. Tsai MS, Bogart DF, Castaneda JM, Li P and Lupu R: Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 21: 8178-8185, 2002.
28. Beattie J: SH2 domain protein interaction and possibilities for pharmacological intervention. Cell Signal 8: 75-86, 1996.
29. Nishinaka Y, Masutani H, Nakamura H and Yodoi J: Regulatory roles of thioredoxin in oxidative stress-induced cellular responses. Redox Rep 6: 289-295, 2001.
30. Sun XH, Copeland NG, Jenkins NA and Baltimore D: Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol 11: 5603-5611, 1991.